Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy

ClinicalTrials.gov ID: NCT00229437

Public ClinicalTrials.gov record NCT00229437. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Three Doses of TAK-128 in Subjects With Mild to Moderate Diabetic Peripheral Neuropathy

Study identification

NCT ID
NCT00229437
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Takeda
Industry
Enrollment
343 participants

Conditions and interventions

Interventions

  • TAK-128 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2005
Primary completion
Apr 30, 2006
Completion
Apr 30, 2006
Last update posted
Feb 27, 2012

2005 – 2006

United States locations

U.S. sites
40
U.S. states
20
U.S. cities
40
Facility City State ZIP Site status
Not listed Mesa Arizona
Not listed Peoria Arizona
Not listed Phoenix Arizona
Not listed Tucson Arizona
Not listed Little Rock Arkansas
Not listed Huntington Beach California
Not listed La Jolla California
Not listed Long Beach California
Not listed Los Angeles California
Not listed Northridge California
Not listed San Francisco California
Not listed Torrance California
Not listed Tustin California
Not listed Aventura Florida
Not listed Fort Myers Florida
Not listed Hialeah Florida
Not listed Miami Florida
Not listed Palm Beach Gardens Florida
Not listed Plant City Florida
Not listed Decatur Georgia
Not listed Chicago Illinois
Not listed Louisville Kentucky
Not listed New Orleans Louisiana
Not listed Boston Massachusetts
Not listed Ann Arbor Michigan
Not listed Flint Michigan
Not listed St Louis Missouri
Not listed Las Vegas Nevada
Not listed Elizabeth New Jersey
Not listed New Brunswick New Jersey
Not listed Buffalo New York
Not listed Staten Island New York
Not listed Greenville North Carolina
Not listed Oklahoma City Oklahoma
Not listed Morrisville Pennsylvania
Not listed Dallas Texas
Not listed Houston Texas
Not listed San Antonio Texas
Not listed Norfolk Virginia
Not listed Tacoma Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00229437, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 27, 2012 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00229437 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →